And its unfortunate that we put the patients in a very awkward situation where they have to go and try therapies that have not been recommended to them by their healthcare professional, and instead have to follow a formulary that was designed as an aggregate all of all the data instead of getting the medicine that was chosen for them by their physician or healthcare professional
measuring whole-brain atrophy requires larger sample sizes and extended longitudinal durations to accurately capture significant results
We've seen this happen countless times
Despite existing limitations, spontaneous reporting may be the best way to find rare AEs
You can learn more by visiting reputable health websites or consulting with healthcare professionals knowledgeable in these supplements
This article examines the current evidence on investigational GLP-1 patches, including potential wearing durations, application methods, and safety considerations, whilst highlighting the licensed injectable alternatives available through the NHS